Mizuho Securities analyst Uy Ear has maintained their bullish stance on ARQT stock, giving a Buy rating on November 11.Don't Miss our Black ...

offering a potential novel avenue for treatment. "We are thrilled to have our first participant enrolled," said Chief Executive Officer Cheri Ackerman. "For the millions of people who suffer from ...

Therefore, even individuals without childhood eczema may experience it later in life. Dr Grant has debunked the common ...

There are lots of misconceptions around eczema, from poor hygiene to the skin condition disappearing on its own - there is a ...

Eczema is relatively common, affecting 20 percent of children and 10 percent of adults around the world (1). If you are one of the many who experiences eczema, you know the symptoms, which can include ...

An Auckland-based artist living with debilitating symptoms of topical steroid withdrawal (TSW) believes his dermatologists ...

Characterised by the overproduction of skin cells, plaque psoriasis leads to itchy or painful inflamed and scaly plaques. Credit: And-One / Shutterstock. Johnson & Johnson (J&J) has reported positive ...

For many, fall is their favourite time of year. The bugs are gone, the leaves are turning colours and the holidays are on the ...

It's just a little creamier! "I absolutely love this wonderful, silky, smooth, make you feel so sexy type of body wash! I ...

ZORYVE cream 0.15% is the first once-daily, Food and Drug Administration (FDA)-approved topical treatment for mild to moderate atopic dermatitisZORYVE, a next-generation topical phosphodiesterase-4 ...

When it comes to medical marketing, some campaigns are built around celebrity spokespeople while others opt for first-person ...